Welcome to our dedicated page for Caci Intl SEC filings (Ticker: CACI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
CACI International Inc filings document the formal disclosures of an operating national security technology company serving U.S. government defense, intelligence and federal civilian customers. Recent Form 8-K reports cover fiscal-quarter results, financial-condition disclosures, material agreements and exhibits tied to the company's operating performance and contract-driven business.
The filing record also documents capital-structure actions, including unsecured senior notes due 2033, related subsidiary guarantees and financing arrangements connected to the completed ARKA Group acquisition. Other disclosures address accounts receivable purchase arrangements, board composition, director independence, compensatory arrangements and other governance matters reported under current-report requirements.
CACI International (CACI) reported an insider equity award. Director Ryan D. McCarthy received 338 Restricted Stock Units on October 16, 2025. These RSUs convert into shares of CACI common stock as they vest: 84 on January 14, 2026; 84 on April 14, 2026; 85 on July 13, 2026; and 85 on October 11, 2026.
The filing shows the grant as an acquisition of derivative securities with direct ownership. RSUs typically represent a form of equity compensation that settles in stock upon vesting, aligning directors’ interests with long-term shareholder value.
CACI International Inc. (CACI) reported an insider transaction on a Form 4. Director Philip O. Nolan acquired 83 shares of CACI common stock on 10/12/2025 via settlement of restricted stock units, noted with transaction code M. After this transaction, he beneficially owned 2,069 shares directly. These RSUs were part of a 331‑unit grant from 10/17/2024 with scheduled vesting of 82 shares on 1/15/2025, 83 shares on 4/15/2025, 83 shares on 7/14/2025, and 83 shares on 10/12/2025.
CACI International (CACI) director Stanton D. Sloane reported the vesting and settlement of 83 Restricted Stock Units on October 12, 2025, resulting in the acquisition of 83 shares of CACI common stock (transaction code M).
Following this transaction, Sloane beneficially owns 859 shares, held directly. The RSUs were part of a 331-unit grant made on October 17, 2024, scheduled to vest in four tranches: 82 shares on January 15, 2025; 83 on April 15, 2025; 83 on July 14, 2025; and 83 on October 12, 2025.
CACI International Inc. (CACI) reported an insider equity change by director Debora A. Plunkett. On October 12, 2025, 83 shares of CACI common stock were acquired via an RSU vesting event (transaction code M). Following this transaction, Ms. Plunkett beneficially owned 2,564 shares, held directly.
The activity relates to a prior grant of 331 Restricted Stock Units awarded on October 17, 2024, with scheduled vesting as follows: 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025.
CACI International Inc.: Director Ryan D. McCarthy reported the vesting and settlement of 83 restricted stock units into CACI common stock on October 12, 2025 (Transaction Code M). Following this transaction, he beneficially owned 2,069 shares directly.
The RSUs were granted on October 17, 2024 (331 total) with a vesting schedule of 82 shares on January 15, 2025, 83 shares on April 15, 2025, 83 shares on July 14, 2025, and 83 shares on October 12, 2025.
CACI International (CACI) director Scott Morrison reported the vesting and settlement of restricted stock units into common stock. On 10/12/2025, a transaction coded M converted RSUs into 83 shares of CACI common stock. Following the transaction, Morrison beneficially owns 331 shares directly.
The activity reflects the final tranche of a previously disclosed 331 RSU grant made on October 17, 2024, which vested in scheduled installments across 2025, concluding with 83 shares on October 12, 2025.
CACI International (CACI) reported an insider equity change by Director William L. Jews. On October 12, 2025, 83 shares of CACI common stock were acquired through the conversion of vested RSUs (Code M), increasing his direct holdings to 6,384 shares.
The transaction reflects the final tranche from a 331 RSU grant awarded on October 17, 2024, which vested in installments: 82 shares on January 15, 2025; 83 shares on April 15, 2025; 83 shares on July 14, 2025; and 83 shares on October 12, 2025.
CACI International Inc. (CACI): Director Charles L. Szews reported the settlement of 83 shares of CACI common stock on 10/12/2025 via the conversion (Code M) of restricted stock units. Following this transaction, he beneficially owns 331 shares, held directly.
The 83-share vesting represents the final tranche of a 331 RSU grant awarded on 10/17/2024, which vested as 82 shares on 01/15/2025, 83 on 04/15/2025, 83 on 07/14/2025, and 83 on 10/12/2025.
CACI International (CACI): Director Lisa Disbrow reported the vesting and settlement of 83 restricted stock units into CACI common stock on 10/12/2025 (transaction code M). Following this transaction, she beneficially owns 1,934 shares, held directly.
The RSUs were part of a 331‑unit grant made on October 17, 2024, vesting in tranches: 82 shares on January 15, 2025; 83 on April 15, 2025; 83 on July 14, 2025; and 83 on October 12, 2025.
CACI International (CACI): Director Susan M. Gordon reported the settlement of restricted stock units into common shares. On 10/12/2025, 83 RSUs vested and converted into 83 shares of CACI common stock (transaction code M), consistent with a previously disclosed grant.
The RSUs were part of a 331-unit award granted on October 17, 2024, vesting in four tranches: 82 shares on January 15, 2025; 83 on April 15, 2025; 83 on July 14, 2025; and 83 on October 12, 2025. Following this vesting, Ms. Gordon directly owns 2,737 CACI shares.
This filing reflects routine equity compensation vesting for a director and does not indicate an open-market purchase or sale.